Radiat Oncol J.  2017 Mar;35(1):32-38. 10.3857/roj.2016.01963.

A novel schedule of accelerated partial breast radiation using intensity-modulated radiation therapy in elderly patients: survival and toxicity analysis of a prospective clinical trial

Affiliations
  • 1Department of Radiation Oncology, University of Vermont Medical Center, Burlington, VT, USA. Ruth.Heimann@uvmhealth.org
  • 2University of Vermont Cancer Center, Burlington, VT, USA.

Abstract

PURPOSE
Several accelerated partial breast radiation (APBR) techniques have been investigated in patients with early-stage breast cancer (BC); however, the optimal treatment delivery techniques remain unclear. We evaluated the feasibility and toxicity of APBR delivered using intensity-modulated radiation therapy (IMRT) in elderly patients with stage I BC, using a novel fractionation schedule.
MATERIALS AND METHODS
Forty-two patients aged ≥65 years, with stage I BC who underwent breast conserving surgery were enrolled in a phase I/II study evaluating APBR using IMRT. Forty eligible patients received 40 Gy in 4 Gy daily fractions. Patients were assessed for treatment related toxicities, and cosmesis, before APBR, during, and after completion of the treatment.
RESULTS
The median age was 73 years, median tumor size 0.8 cm and the median follow-up was 54 months. The 5-year locoregional control was 97.5% and overall survival 90%. Erythema and skin pigmentation was the most common acute adverse event, reported by 27 patients (69%). Twenty-six patients (65%) reported mild pain, rated 1-4/10. This improved at last follow-up to only 2 (15%). Overall the patient and physician reported worst late toxicities were lower than the baseline and at last follow-up, patients and physicians rated cosmesis as excellent/good in 93% and 86 %, respectively.
CONCLUSION
In this prospective trial, we observed an excellent rate of tumor control with daily APBR. The acceptable toxicity profile and cosmetic results of this study support the use of IMRT planned APBR with daily schedule in elderly patients with early stage BC.

Keyword

Breast neoplasms; Intensity-modulated radiotherapy; Dose hypofractionation

MeSH Terms

Aged*
Appointments and Schedules*
Breast Neoplasms
Breast*
Dose Hypofractionation
Erythema
Follow-Up Studies
Humans
Mastectomy, Segmental
Prospective Studies*
Radiotherapy, Intensity-Modulated
Skin Pigmentation
Full Text Links
  • ROJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr